MILPITAS, Calif. – Bigfoot Biomedical is in the final development stages of its smartloop automated insulin delivery service, thanks to a recent Series A investment of $35.5 million. “Bigfoot Biomedical is only the second company in the world to embed a closed loop control algorithm in a sensor augmented insulin pump,” said Jeffrey Brewer, Bigfoot founder and CEO. The core of the monthly service is a cloud-connected ecosystem for diabetes management, interfacing with wearable insulin delivery and glucose monitoring tools, all accessible through a secure mobile app. The smartloop solution is accessible with a prescription, and reimbursed as a service for a monthly fee.
You are here: / / Bigfoot Biomedical readies automated insulin delivery service